je.st
news
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
2013-11-04 12:23:21| Biotech - Topix.net
Active Biotech announced today that its partner Teva Pharmaceutical Industries Ltd. will initiate a further clinical trial, LIBRETTO, to evaluate the efficacy, safety and tolerability of two doses of oral laquinimod , compared to interferon beta-1a, in patients with relapsing remitting multiple sclerosis.
Tags: partner
active
multiple
trial
Category:Biotechnology and Pharmaceuticals